Latest filing published 18 Sept 2024 for Bicara Therapeutics Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
FIL Ltd: trading record in brief
FIL Ltd discloses dealings in 6 companies, chiefly Denali Therapeutics Inc., Structure Therapeutics Inc. and Bicara Therapeutics Inc. Over a trading history stretching from 12 December 2017 to 16 September 2024, the count stands at 37 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 18 September 2024 with a transaction in Bicara Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to FIL Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 54,092 sharesCommon StockSEC:0000950170-24-107661:0
- 4,013,678 sharesOrdinary SharesSEC:0000318989-23-000054:0
- 218,705 sharesCommon StockSEC:0000318989-21-000078:0
3 of 3 declarations
